Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TOPIRAMATE | 100MG | TABLET | Resolved | 2021-01-28 | 2021-02-11 | 132649 |
| TREANDA | 100MG | POWDER FOR SOLUTION | Resolved | 2021-01-28 | 2021-02-11 | 132644 |
| TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2021-01-22 | 2021-02-11 | 132267 |
| TEVA-GABAPENTIN | 800MG | TABLET | Resolved | 2021-01-15 | 2021-02-11 | 131694 |
| TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-01-15 | 2021-02-11 | 131682 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2020-12-17 | 2021-02-11 | 130288 |
| TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-11-27 | 2021-02-11 | 129045 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2020-03-19 | 2021-02-11 | 109056 |
| TEVA-VARENICLINE | 0.5MG | TABLET | Actual shortage | 2021-02-05 | 2021-02-05 | 133473 |
| TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-28 | 2021-02-05 | 132639 |
| FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2021-01-28 | 2021-02-05 | 132630 |
| TEVA-LISINOPRIL/HCTZ (TYPE Z) | 10MG 12.5MG | TABLET | Resolved | 2021-01-15 | 2021-02-05 | 131700 |
| TEVA-LISINOPRIL (TYPE Z) | 5MG | TABLET | Resolved | 2021-01-15 | 2021-02-05 | 131697 |
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2021-01-07 | 2021-02-05 | 131078 |
| TEVA-QUININE | 300MG | CAPSULE | Resolved | 2021-01-07 | 2021-02-05 | 131072 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2021-01-07 | 2021-02-05 | 131066 |
| TEVA-LISINOPRIL (TYPE Z) | 20MG | TABLET | Resolved | 2020-12-17 | 2021-02-05 | 130310 |
| TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2020-12-17 | 2021-02-05 | 130307 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Resolved | 2020-12-17 | 2021-02-05 | 130304 |
| FENTORA | 100MCG | TABLET (EFFERVESCENT) | Resolved | 2020-11-19 | 2021-02-05 | 128600 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |